Legacy Capital Group California, Inc.

Position in BMY — Bristol Myers Squibb Co

CIK 1977092 LOS GATOS, CA

Position in BMY

as of Jun 30, 2026 · filed Jul 29, 2026 Compact

Position Value

$867,296

-$69,018 QoQ

Shares Held

15,052

-2.5% QoQ

Ownership

0.001%

of shares outstanding

% of Portfolio

0.36%

of 13F equity value

Holder Rank

#1,249

of 2,506 holders

Holding Since

Mar 2023

13 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Legacy Capital Group California, Inc. holds $8,650,056 across 9 Drug Manufacturers - General names. BMY ranks #4 (10.0% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	MRK	Merck & Co., Inc.	19,689	$2,530,036
2	JNJ	Johnson & Johnson	6,006	$1,525,343
3	PFE	Pfizer Inc	37,682	$907,382
4	BMY	Bristol Myers Squibb Co This page	15,052	$867,296
5	AMGN	Amgen Inc	2,351	$851,344
6	BIIB	Biogen Inc.	2,844	$614,474
7	GILD	Gilead Sciences, Inc.	4,088	$516,477
8	NVO	Novo Nordisk A S	10,299	$493,734

13 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$867,296	15,052	-2.5%	Shares	Sole	2026-07-29
2026-03-31	$936,314	15,438	-25.0%	Shares	Sole	2026-05-04
2025-12-31	$1,110,732	20,592	+2.1%	Shares	Sole	2026-01-28
2025-09-30	$909,396	20,164	-27.5%	Shares	Sole	2025-11-12
2025-06-30	$1,286,630	27,795	+97.2%	Shares	Sole	2025-07-14
2025-03-31	$859,715	14,096	+114.6%	Shares	Sole	2025-05-09
2024-12-31	$371,486	6,568	+0.1%	Shares	Sole	2025-02-03
2024-09-30	$339,466	6,561	-2.6%	Shares	Sole	2024-10-23
2024-06-30	$279,621	6,733	+76.7%	Shares	Sole	2024-07-22
2024-03-31	$206,670	3,811	-1.4%	Shares	Sole	2024-05-07
2023-09-30	$224,266	3,864	-0.9%	Shares	Sole	2023-11-06
2023-06-30	$249,277	3,898	+3.4%	Shares	Sole	2023-08-10
2023-03-31	$261,298	3,770	—	Shares	Sole	2023-05-11
No filing history on record for this holder in this stock.